View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
December 11, 2019

Nihon Kohden introduces new vital signs monitoring device

US-based Nihon Kohden has introduced a new portable vital signs monitoring tool with customisable early warning scoring.

US-based Nihon Kohden has introduced a new portable vital signs monitoring tool with customisable early warning scoring.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Designed for outpatient facilities, the Life Scope SVM-7200 Series measures blood oxygen, blood pressure and temperature.

The newly launched device combines vital signs data and observational data, enabling physicians to assess patient condition promptly.

If the device identifies a patient with a high risk of deterioration, the monitor then converts to a continuous monitoring mode, which in turn allows clinicians to view vital functions within the Nihon Kohden Patient Monitoring System.

The device also features a high-resolution, eight-inch colour touchscreen display.

Nihon Kohden America clinical and strategic alliances vice-president Veffa Devers said:  “Even patients who seem stable can unexpectedly decline. Most will exhibit gradual changes in vital signs hours before they decline, such as a gradual increase in temperature and heart rate or a subtle, yet progressive change in blood pressure and pulse oximetry.

“These changes can be a signal that a patient is at risk for a larger health concern, such an infection or hemodynamics decline. Regular and consistent monitoring of vital signs combined with our customisable early warning scoring can help clinicians identify these patients early and intervene before the situation becomes critical.”

Furthermore, the device features Nihon Kohden’s inflation-based non-invasive blood pressure (iNIBP) measuring tool, which automatically detects diastolic and systolic pressure while the cuff is inflating.

The Life Scope SVM-7200 Series vital signs monitoring device will soon be equipped with a two-touch send-to-EMR feature.

Nihon Kohden America president and CEO Yasuhiro Yoshitake said: “Our goal is to design monitors that allow clinicians to spend more time with their patients and less time with the technology. With the Life Scope SVM-7200, we have fulfilled this promise.

“It has an elegant, intuitive design that can be patient-ready in a matter of minutes and can be easily moved from room to room as required. Initial user training for the monitor is easy and can be accomplished in less than an hour, and an on-screen tutorial is available whenever needed.”

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network